Skip to Content

WPI 2232 (Tamoxifen 10 mg)

Pill with imprint WPI 2232 is White, Round and has been identified as Tamoxifen citrate 10 mg. It is supplied by Watson Pharmaceuticals, Inc..

Tamoxifen is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant; breast cancer, male; breast cancer, palliative (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2232

Tamoxifen citrate 10 mg WPI 2232
Tamoxifen citrate 10 mg WPI 2232
Tamoxifen citrate 10 mg WPI 2232

Tamoxifen citrate

WPI 2232
10 mg
Prescription only
Drug Class:
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals, Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.